Medtronic expanding imaging in India; Hospira strikes deal to get pumps back on U.S. market;

 @FierceMedDev: J&J device revenue jumped 6.4% in 2012 thanks to Synthes buy. Report | Follow @FierceMedDev

 @DamianFierce: If $LIFE is indeed for sale, that's not stopping it from pursuing more M&A of its own. More | Follow @DamianFierce

> Medtronic ($MDT) is working to expand its O-Arm Intra-operative 3-D surgical imaging device in India, in keeping with CEO Omar Ishrak's goal of boosting the company's presence in emerging markets. Article

> SafeStitch Medical got some positive results for its GERD- and obesity-treating device, and the company is planning to submit an IDE this year and pursue full FDA approval. More

> Hospira ($HSP) has entered into a deal with Q Core Medical, giving the company exclusive rights to market and distribute Q Core's Sapphire infusion pump. The agreement opens up a revenue stream for Hospira after the FDA blocked the importation of its Symbiq pumps back in November. News | Background

> Moog Medical Devices is expanding its recall of administration sets to include another production lot. Item

> Mallinckrodt, Covidien's ($COV) soon-to-be-spun-out drug business, got FDA approval for a prefilled-syringe variety of Gablofen, a treatment for spinal spasticity. Release

> Teleflex ($TFX) snagged FDA clearance for its Arrow UltraQuik peripheral nerve block needles. Report

> Israel's Brainsway ($BRIN) expects to find a commercialization partner this quarter for its recently FDA-approved device to treat depression. Story

Biotech News

 @FierceBiotech: Novo Nordisk nabs European OK on blockbuster diabetes drug hopeful. News | Follow @FierceBiotech

@JohnCFierce: As CRL letters go, Impax would seem to have a low hurdle ahead on its sustained release Parkinson's drug. More | Follow @JohnCFierce

@RyanMFierce: Software outfit tackles multi-billion dollar bugaboo in clinical trials. Article | Follow @RyanMFierce

> New $80M venture fund to back startups entering 'valley of death.' Story

> Biotech vet Astley-Sparke takes U.S. lead for pioneering gene therapy player. Article

Pharma News

@FiercePharma: ADHD diagnoses up 24% over past 10 years; study author cites "better diagnosis" and possible "upward trend." More | Follow @FiercePharma

 @AlisonBFierce: Vanderbilt University has emerged as a leading institution for central nervous system drug research and discovery. Editor's Corner | Follow @AlisonBFierce

@EricPFierce: Plant problems stymie Impax NDA for Parkinson drug, FDA says. Article | Follow @EricPFierce

> Amgen's Sensipar scored pricing shield from Congress. News

> Novo ready to rev up Tresiba for European launch. Report

Biotech IT News

> New chief named for Perceptive Informatics. Story

> U.K. regulator finds social media groove…finally. Item

> Software outfit tackles multi-billion dollar bugaboo in clinical trials. Article

> Elsevier rumored as potential buyer of open science startup. News

CRO News

> Is GlaxoSmithKline stretching its contractors too thin? Story

> Covance teams with U.K.'s NHS Trust on Phase I trials. Report

> Clinipace rejiggers eClinical platform. Article

> Quintiles lands pathology accreditation for Indian lab. News

Pharma Manufacturing News

> BASF lands Pronova making it a top omega-3 maker. Report

> Pfizer to develop laser cleaning verification system. Item

> Cargo theft down in year of key arrests. News

> Plant problems stymie Impax NDA, FDA says. Article

Biotech Research News

> Calcium receptor could stop sleeping sickness in its tracks. Item

> Oral breast cancer vaccine could prevent recurrence. Article

> A great leap forward: Microdystrophin gene therapy success in dogs. Report

> Glowing mice could blaze way for detecting, tracking cancer growth. News

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.